You searched for "BURST"

590 results found

An algorithm for the management of haemorrhagic cystitis

Haemorrhagic cystitis (HC) can be one of the most difficult conditions to treat in urological practice. It is characterised by intractable bleeding from the bladder and may be acute or chronic. The most frequently reported causal factors are radiotherapy (RT)...

An MA in medical education – is it for you?

I have recently completed a three-year MA in medical education at the University of Winchester, which has been an edifying experience. The following article may appeal to readers who are considering such a venture. I have been a consultant for...

How an ergonomic design is helping women overcome barriers in ISC

Urinary incontinence, or loss of bladder control, is a frustrating problem for millions of people. Never knowing when and where one might have an accident can affect everything: from work to family and social life. It happens to both men...

Bike4TUF goes local to raise vital funds and support patients

There was no stopping urologists from raising vital funds for charity as they cycled more than 2000 miles to support The Urology Foundation (TUF). The annual Bike4TUF event saw 24 participants cycle in teams of six across Manchester, Canterbury, London,...

Can we make LATE-presenting posterior urethral valves an EARLIER-treated condition?

What are posterior urethral valves? Posterior urethral valve (PUV) is the most common cause of congenital bladder outlet obstruction (BOO) and renal failure in male children. They were first described by the Italian anatomist Giovanni Battista Morgagni back in the...

One cycle of adjuvant chemotherapy in tumours of the testis

Following a radical orchiectomy, current UK practice for newly diagnosed, high-risk, stage 1 nonseminomatous or combined germ cell tumours of the testis (NSCGCTT) is either two cycles of adjuvant chemotherapy with bleomycin, etoposide, cisplatin (BE360Px2) or surveillance with BE500Px3 on...

Action Bladder Cancer UK – 2019 Report

ABC UK is a national charity working for bladder cancer patients. Set up in 2009 we work to raise awareness of bladder cancer and the issues faced by patients; we provide direct support for patients; we work to improve outcomes for...

Anti-VEGF and PD-1 combinations in renal cell carcinoma

Over the past decade, vascular endothelial growth factor (VEGF) tyrosine kinase inhibitors (TKIs) have been central to treating renal cell carcinoma (RCC), with oncologists refining dosing strategies to balance treatment efficacy with quality of life (QoL). Recently, the introduction of...

Femeda Ltd Wins Prestigious Medilink Partnership with Academia Award

Partnership with Academia Award Winner: Femeda Ltd Femeda has committed to the first real world clinical trial for a consumer medical device globally to be run in Manchester. Femeda is extending the partnership with engagement of Phd students from the...

Thomas Molyneux and the lost bodkin

In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). In an earlier article we looked at one of the medals in the...

Geoffrey Parker (1902-1973) – urologist to the French Resistance!

In this series of articles I am going to show you some of the exhibits contained in the Museum of Urology, hosted on the BAUS website (www.baus.org.uk). This time, I am joined by Jasmine Winyard, urology trainee in Leicester; we...

I wasn’t expecting that! A series of unexpected radiology findings

Case 1 A 76-year-old diabetic man with a long-term catheter presents to the Emergency Department with rigors and non-specific abdominal pain. He has an elevated white cell count (WCC) and C-reactive protein (CRP). An abdominal and pelvic CT scan was...